[go: up one dir, main page]

WO2013053034A3 - Tiazacridinas utilizadas na terapia anticâncer - Google Patents

Tiazacridinas utilizadas na terapia anticâncer Download PDF

Info

Publication number
WO2013053034A3
WO2013053034A3 PCT/BR2012/000421 BR2012000421W WO2013053034A3 WO 2013053034 A3 WO2013053034 A3 WO 2013053034A3 BR 2012000421 W BR2012000421 W BR 2012000421W WO 2013053034 A3 WO2013053034 A3 WO 2013053034A3
Authority
WO
WIPO (PCT)
Prior art keywords
thiazacridines
cancer therapy
denominated
thiazolidine
acridinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/BR2012/000421
Other languages
English (en)
French (fr)
Other versions
WO2013053034A2 (pt
Inventor
GALDINO. Suely LINS
Ivan Da Rocha Pitta
CARMO ALVES DE LIMA. María DO
Marina GALDINO DA ROCHA PITTA
Francisco Washington ARAUJO BARROS
Claudia DO Ó PESSOA
Manoel Odorico DE MORAES FILHO
Maira Galdino DA ROCHA PITTA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSIDADE FEDERAL DE PERNAMBUCO - UFPE
Universidade Federal Do Ceara - Ufc
Original Assignee
UNIVERSIDADE FEDERAL DE PERNAMBUCO - UFPE
Universidade Federal Do Ceara - Ufc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIVERSIDADE FEDERAL DE PERNAMBUCO - UFPE, Universidade Federal Do Ceara - Ufc filed Critical UNIVERSIDADE FEDERAL DE PERNAMBUCO - UFPE
Publication of WO2013053034A2 publication Critical patent/WO2013053034A2/pt
Publication of WO2013053034A3 publication Critical patent/WO2013053034A3/pt
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A presente invenção é relativa a compostos derivados da 3-acridinilmetil-tiazolidina- 2,4-diona, também denominados tiazacridinas, bem como aos respectivos processos para sua síntese química, bem como seu uso terapêutico no tratamento do câncer.
PCT/BR2012/000421 2011-10-10 2012-10-24 Tiazacridinas utilizadas na terapia anticâncer Ceased WO2013053034A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI1106333 2011-10-10
BRPI1106333-5 2011-10-10

Publications (2)

Publication Number Publication Date
WO2013053034A2 WO2013053034A2 (pt) 2013-04-18
WO2013053034A3 true WO2013053034A3 (pt) 2013-06-27

Family

ID=48082600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2012/000421 Ceased WO2013053034A2 (pt) 2011-10-10 2012-10-24 Tiazacridinas utilizadas na terapia anticâncer

Country Status (1)

Country Link
WO (1) WO2013053034A2 (pt)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024058A2 (en) * 2002-09-10 2004-03-25 Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq Molecules with antitumor activity and chemical synthesis
WO2007109871A2 (en) * 2006-03-24 2007-10-04 Universidade Federal De Pernambuco - Ufpe Acridine derivatives with antitumoral activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024058A2 (en) * 2002-09-10 2004-03-25 Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq Molecules with antitumor activity and chemical synthesis
WO2007109871A2 (en) * 2006-03-24 2007-10-04 Universidade Federal De Pernambuco - Ufpe Acridine derivatives with antitumoral activity

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
R.H. MOURAO ET AL.: "Synthesis and Biological Activity of Novel Acridinylidene and Benzylidene thiazolidinediones", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 40, 2005, pages 1129 - 1133, XP005113105 *
WILLIAM A. DENNY: "Acridine Derivatives as Chemotherapeutic Agents", CURRENT MEDICINAL CHEMISTRY, vol. 9, 2002, pages 1655 - 1665, XP009073854 *

Also Published As

Publication number Publication date
WO2013053034A2 (pt) 2013-04-18

Similar Documents

Publication Publication Date Title
IL279330A (en) Combined treatment including antibodies against Claudin 18.2 for the treatment of cancer
IL276434A (en) Combined treatment involving antibodies against claudin 18.2 for the treatment of cancer
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
WO2013114367A8 (en) C10rf32 antibodies, and uses thereof for treatment of cancer
IL240060A0 (en) Treatment involving antibodies against claudin 2. 18 for the treatment of cancer
AU2011328009A8 (en) Compounds and methods for treating pain
MX2014011134A (es) Compuestos de carbamato y preparacion y uso de los mismos.
PH12014502406B1 (en) Anti-il-23p19 antibodies
WO2012103810A1 (en) Certain chemical entities, compositions, and methods
IN2015MN00001A (pt)
PH12015501088A1 (en) Dimeric compounds
SI2852408T1 (sl) Kombinacijska terapija, ki vključuje protitelesa proti claudin 18.2 za zdravljenje raka
WO2007140804A8 (en) A process for the preparation of an oxaliplatin
WO2013053034A3 (pt) Tiazacridinas utilizadas na terapia anticâncer
WO2012158776A3 (en) Combination therapy for treatment of cancer
HK40110865A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
HK40087661A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
HK40092402A (en) Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
HK1213581A1 (zh) 抗-cd40抗体及其使用方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12839760

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12839760

Country of ref document: EP

Kind code of ref document: A2